Medi-Caps Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-5.71	-22.41	17.56	100.81	111.29
Depreciation & Amortization	17.18	16.87	18.11	19.03	18.52
Other Operating Activities	8.43	46.38	6.66	14.4	27.4
Change in Accounts Receivable	20.27	-23.53	16.08	-36.85	-19.81
Change in Inventory	25.36	13.33	47.81	-51.44	-12.6
Change in Other Net Operating Assets	-14.84	38.75	-165.91	23.89	29.54
Operating Cash Flow	50.69	69.39	-60.81	70.21	153.19
Operating Cash Flow Growth	-26.95%	-	-	-54.17%	230.83%
Capital Expenditures	-3.26	-3.46	-11.63	-27.94	-22.57
Investment in Securities	-46.59	-73.89	-14	-12.82	-74.42
Other Investing Activities	0.07	0.04	0.03	-	-
Investing Cash Flow	-49.78	-77.31	-25.6	-40.75	-96.99
Short-Term Debt Repaid	-	-	-	-	-0.64
Total Debt Repaid	-	-	-	-	-0.64
Net Debt Issued (Repaid)	-	-	-	-	-0.64
Financing Cash Flow	-	-	-	-	-0.64
Miscellaneous Cash Flow Adjustments	-	-	-0	0	0
Net Cash Flow	0.91	-7.92	-86.41	29.46	55.56
Free Cash Flow	47.43	65.93	-72.44	42.28	130.62
Free Cash Flow Growth	-28.06%	-	-	-67.64%	286.92%
Free Cash Flow Margin	18.62%	24.11%	-14.67%	6.05%	22.25%
Free Cash Flow Per Share	3.80	5.29	-5.81	3.39	10.47
Cash Income Tax Paid	-2.56	10.06	30.56	-	-
Levered Free Cash Flow	21.54	-12.83	19.24	-22.55	60.1
Unlevered Free Cash Flow	21.69	-12.83	19.25	-22.49	60.1
Change in Working Capital	30.79	28.55	-102.03	-64.4	-2.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.